Lidocaine Hydrochloride Noridem (Lidocaine Hydrochloride Monohydrate)

Lidocaine works by blocking voltage‑gated sodium channels on nerve membranes, which prevents the rapid influx of sodium ions needed for depolarization. This interruption stops the initiation and conduction of nerve impulses, resulting in reversible loss of sensation in the area where it is applied.

The appropriate dose of Lidocaine Hydrochloride Noridem is determined by the prescribing clinician based on the procedure, patient weight, age, and clinical condition. Healthcare professionals calculate the dose to achieve effective anesthesia while staying within safe concentration limits.

Safety data for Lidocaine Hydrochloride Noridem in pregnancy and lactation are limited. It should be used only when the potential benefit justifies any possible risk to the fetus or infant, and the decision should be made by a qualified healthcare provider.

To order, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain requirements) and necessary import documentation.

Lidocaine has a relatively rapid onset and moderate duration of action compared with bupivacaine, which has a slower onset but longer duration. Lidocaine is often preferred for shorter procedures or when quick recovery of sensation is desired, whereas bupivacaine may be chosen for prolonged postoperative analgesia.

Lidocaine Hydrochloride Noridem should be stored at ambient temperature, below 25 °C, in its original sealed container. Protect the solution from moisture, direct sunlight, and extreme temperature fluctuations. Do not freeze the product, and inspect the vial for any particulate matter before use.

The product is supplied as a sterile injectable solution and is administered by a qualified healthcare professional via epidural, intradermal or intramuscular injection, depending on the clinical indication. Proper aseptic technique and accurate dosing are essential for safe use.

Serious risks include severe allergic reactions (anaphylaxis), cardiac arrhythmias, central nervous system seizures, methemoglobinemia, and respiratory depression. Immediate medical attention is required if any of these events occur during or after administration.

Patients with a known hypersensitivity to lidocaine or other amide‑type local anesthetics, those with severe heart block, uncontrolled epilepsy, or significant hepatic impairment should avoid using this product unless a specialist determines that benefits outweigh risks.